» Articles » PMID: 31043670

Pyrogen Retention: Comparison of the Novel Medium Cut-off (MCO) Membrane with Other Dialyser Membranes

Overview
Journal Sci Rep
Specialty Science
Date 2019 May 3
PMID 31043670
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Haemodialysis effectively removes small solutes and smaller-sized middle molecules from the blood; however, the clearance of larger middle molecules, which have been associated with negative effects, is poor. The novel medium cut-off (MCO) dialysis membrane has larger pore sizes and a more open structure than other high-flux membranes, providing improved removal of larger middle molecules while retaining albumin. However, larger pore sizes may potentially increase permeability to pyrogens, including endotoxins and other bacterial contaminants, that could be present in the dialysis fluid. In this study, we tested the capacity of low-flux, high-flux, MCO and high cut-off dialyser membranes with different pore sizes to prevent pyrogens crossing from dialysate to the blood side in a closed-loop test system, differentiating among lipopolysaccharides, peptidoglycans and bacterial DNA using a toll-like receptor assay. Even though the bacterial contamination levels in our test system exceeded the acceptable pyrogen dose for standard dialysis fluid, levels of lipopolysaccharides, peptidoglycans and bacterial DNA in the blood-side samples were too low to identify potential differences in pyrogen permeability among the membranes. Our results suggest that MCO membranes are suitable for haemodialysis using ISO standard dialysis fluid quality, and retain endotoxins at a similar level as other membranes.

Citing Articles

Effects of Expanded Hemodialysis with Medium Cut-Off Membranes on Maintenance Hemodialysis Patients: A Review.

Zhang Z, Yang T, Li Y, Li J, Yang Q, Wang L Membranes (Basel). 2022; 12(3).

PMID: 35323729 PMC: 8953230. DOI: 10.3390/membranes12030253.


The Next Evolution of HemoDialysis eXpanded: From a Delphi Questionnaire-Based Approach to the Real Life of Italian Dialysis Units.

Dellepiane S, Marengo M, DArezzo M, Donati G, Fabbrini P, Lacquaniti A Blood Purif. 2022; 51(11):943-952.

PMID: 35231902 PMC: 9808684. DOI: 10.1159/000522038.


Classification of Uremic Toxins and Their Role in Kidney Failure.

Rosner M, Reis T, Husain-Syed F, Vanholder R, Hutchison C, Stenvinkel P Clin J Am Soc Nephrol. 2021; 16(12):1918-1928.

PMID: 34233920 PMC: 8729494. DOI: 10.2215/CJN.02660221.


Expanded Haemodialysis as a Current Strategy to Remove Uremic Toxins.

Ciceri P, Cozzolino M Toxins (Basel). 2021; 13(6).

PMID: 34073439 PMC: 8226798. DOI: 10.3390/toxins13060380.


Disruptive technologies for hemodialysis: medium and high cutoff membranes. Is the future now?.

Reis T, Anwar S, Neves F, Ronco C J Bras Nefrol. 2021; 43(3):410-416.

PMID: 33836041 PMC: 8428648. DOI: 10.1590/21758239-JBN-2020-0273.


References
1.
Boschetti-de-Fierro A, Voigt M, Storr M, Krause B . MCO Membranes: Enhanced Selectivity in High-Flux Class. Sci Rep. 2015; 5:18448. PMC: 4680880. DOI: 10.1038/srep18448. View

2.
Krug A, Rothenfusser S, Hornung V, Jahrsdorfer B, Blackwell S, Ballas Z . Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells. Eur J Immunol. 2001; 31(7):2154-63. DOI: 10.1002/1521-4141(200107)31:7<2154::aid-immu2154>3.0.co;2-u. View

3.
Zickler D, Schindler R, Willy K, Martus P, Pawlak M, Storr M . Medium Cut-Off (MCO) Membranes Reduce Inflammation in Chronic Dialysis Patients-A Randomized Controlled Clinical Trial. PLoS One. 2017; 12(1):e0169024. PMC: 5234772. DOI: 10.1371/journal.pone.0169024. View

4.
Jofre R, Rodriguez-Benitez P, Lopez-Gomez J, Perez-Garcia R . Inflammatory syndrome in patients on hemodialysis. J Am Soc Nephrol. 2006; 17(12 Suppl 3):S274-80. DOI: 10.1681/ASN.2006080926. View

5.
Burger-Kentischer A, Abele I, Finkelmeier D, Wiesmuller K, Rupp S . A new cell-based innate immune receptor assay for the examination of receptor activity, ligand specificity, signalling pathways and the detection of pyrogens. J Immunol Methods. 2010; 358(1-2):93-103. DOI: 10.1016/j.jim.2010.03.020. View